Patient Voices Were Heard: Preserving Access to Life Saving Drug Therapies!

2019-05-21T16:16:21+00:00May 21st, 2019|Hot Topics, News|

On May 17, 2019, The Centers for Medicare & Medicaid Services (CMS) released the final Medicare Part D Rule, where they decided to preserve the original Six Protected Classes policy. GO2 Foundation for Lung Cancer (formerly Lung Cancer Alliance and the Bonnie J. Addario Lung Cancer Foundation) advocated to stop the initial proposal that would have excluded certain drugs, including the Six Protected Classes from the Medicare Plan formularies. The Six Protected Classes policy was established over a decade ago to [...]

LCA Joins ACS CAN in Efforts to Protect Patient Access to Lifesaving Treatment

2019-01-17T20:05:01+00:00January 17th, 2019|Hot Topics, News|

Thursday, January 17 – Lung Cancer Alliance joins a long list of leading patient advocacy groups in support of American Cancer Society Cancer Action Network’s (ASC CAN) advertising campaign, urging the U.S. Administration and Congress not to limit patient access to lifesaving medications covered under Medicare, and to ensure the Six Protected Classes policy is preserved. The Six Protected Classes policy offers patients access to cutting-edge FDA-approved therapies for epilepsy, mental illness, cancer, HIV-Aids and organ transplants. A proposal from [...]